In addition to these genetic disorders, the production of inflammatory cytokines, such as interleukin-6 (IL-6) [11,12] and matrix metalloproteinases (MMPs) [13], which lead to extracellular matrix degradation resulting in fragility of the vascular wall, have been implicated in the development of AD. This evidence concerns the gene IL6 and hereditary disease.